As nations adopt regulatory measures for e-cigarettes, it is imperative to understand how approaches to risk, cost-benefit, and trade-offs have shaped interpretations of evidence
No takes yet. Share an insight, caveat, or question.
Fairchild et al. (2015) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: